Indometacin

Indometacin
Clinical data
Pronunciation/ɪndˈmɛtəsɪn/
Trade namesIndocid, Indocin
Other namesIndomethacin (USAN US)
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: C
Routes of
administration
By mouth, rectal, intravenous, topical
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability~100% (oral), 80–90% (rectal)
Protein binding99%[1]
MetabolismLiver
Elimination half-life2.6-11.2 hours (adults), 12-28 hours (infants)[1]
ExcretionKidney (60%), fecal (33%)
Identifiers
IUPAC name
  • 2-{1-[(4-Chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
PDB ligand
CompTox Dashboard (EPA)
ECHA InfoCard100.000.170
Chemical and physical data
FormulaC19H16ClNO4
Molar mass357.79 g·mol−1
3D model (JSmol)
SMILES
  • Cc1c(c2cc(ccc2n1C(=O)c3ccc(cc3)Cl)OC)CC(=O)O
InChI
  • InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23) Y
  • Key:CGIGDMFJXJATDK-UHFFFAOYSA-N Y
  (verify)

Indometacin, also known as indomethacin, is a nonsteroidal anti-inflammatory drug (NSAID) commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. It works by inhibiting the production of prostaglandins, endogenous signaling molecules known to cause these symptoms. It does this by inhibiting cyclooxygenase, an enzyme that catalyzes the production of prostaglandins.[1][2]

It was patented in 1961 and approved for medical use in 1963.[3][4] It is on the World Health Organization's List of Essential Medicines.[5] In 2022, it was the 256th most commonly prescribed medication in the United States, with more than 1 million prescriptions.[6][7]

  1. ^ a b c Brayfield A, ed. (14 January 2014). "Indometacin". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 22 June 2014.
  2. ^ "TGA Approved Terminology for Medicines, Section 1 – Chemical Substances" (PDF). Therapeutic Goods Administration, Department of Health and Ageing, Australian Government. July 1999. p. 70.
  3. ^ Hart FD, Boardman PL (October 1963). "Indomethacin: A New Non-steroid Anti-inflammatory Agent". British Medical Journal. 2 (5363): 965–970. doi:10.1136/bmj.2.5363.965. PMC 1873102. PMID 14056924.
  4. ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 517. ISBN 9783527607495.
  5. ^ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
  6. ^ "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
  7. ^ "Indomethacin Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.